▶ 調査レポート

構造心臓装置の世界市場:市場規模、シェア、成長、動向、予測

• 英文タイトル:Structural Heart Devices Market (Product: Biological/Tissue Valves, Mechanical Heart Valves, Annuloplasty Rings, Occluders, and Accessories; Procedure: Replacement Procedures and Repair Procedures; Indication: Valve Stenosis, Valve Regurgitation, Cardiomyopathy, Congenital Heart Defects, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。構造心臓装置の世界市場:市場規模、シェア、成長、動向、予測 / Structural Heart Devices Market (Product: Biological/Tissue Valves, Mechanical Heart Valves, Annuloplasty Rings, Occluders, and Accessories; Procedure: Replacement Procedures and Repair Procedures; Indication: Valve Stenosis, Valve Regurgitation, Cardiomyopathy, Congenital Heart Defects, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-NV014資料のイメージです。• レポートコード:TPM-NV014
• 出版社/出版日:Transparency Market Research / 2019年8月27日
• レポート形態:英文、PDF、230ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥846,070 (USD5,795)▷ お問い合わせ
  Multi User¥1,284,070 (USD8,795)▷ お問い合わせ
  Global Site License¥1,722,070 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、構造心臓装置の世界市場について調べ、構造心臓装置の世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別(生体/組織弁、機械的心臓弁、弁形成リング、オクルーダー、およびアクセサリー)分析、処置別(交換処置&修理処置)分析、疾患別(弁狭窄、弁逆流、心筋症、先天性心疾患、およびその他)分析、関連企業情報などをまとめました。
・構造心臓装置の市場概要
・構造心臓装置の市場動向
・構造心臓装置の世界市場規模・予測
・構造心臓装置市場:製品別(生体/組織弁、機械的心臓弁、弁形成リング、オクルーダー、およびアクセサリー)
・構造心臓装置市場:処置別(交換処置&修理処置)
・構造心臓装置市場:処置別(交換処置&修理処置)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Structural Heart Devices Market – Scope of the Report

TMR’s recent publication on the structural heart devices market for the forecast period of 2019-2027 is the result of detailed and comprehensive analysis provided by its top-rated analysts. The report provides projections in terms of both, value (US$ Mn) and volume (million units) for statistical evaluation of the structural heart devices market. Objective insights of the structural heart devices market provided herein will equip stakeholders in making impactful business decisions. So much so, the analysis provided is deemed to be game-changing for competitive dynamics in the structural heart devices market.

The report studies the past and current growth trends to provide reliable insights for the structural heart devices market for the 2019-2027 forecast period. Market indices including demand drivers, restraints, threats, and opportunities have been studied at length for their impact on the structural heart devices market for the forecast period. Analysis of SWOTs of the entire structural heart devices market over the forecast period is a highlight of this report.

The report on the structural heart devices market is prepared using industry-centric tools and proven research methodologies. Porter’s Five Forces analysis and SWOT analysis are some tools employed in an attempt to gather information on industry strongholds as well as areas for scope of improvement.

Apart from this, the competitive analysis of players in the structural heart devices market is a key feature of this report. This entails insights into mergers, acquisitions, partnerships, R&D, and technological innovations of key players to accelerate growth in the structural heart devices landscape.

Structural Heart Devices Market – Segmentation

In order to understand the finer details of the market, the report segments the structural heart devices market on the basis of product, procedure, indication, and region.
Structural Heart Devices Market – Key Questions Answered in the Report

Adopting a holistic approach to analyze the structural heart devices market, authors of this report have provided answers to some critical questions pertinent to the said market;

What are the key factors influencing growth in key regions of the structural heart devices market?
What are prevalent trends and how are they likely to impact the scope of the structural heart devices market over the forecast period?
What is the stance of players for growth in the structural heart devices market?
What are revenue shares of key segments under various criteria in the structural heart devices market?
What are the key developments likely to come to the fore in the structural heart devices market at the end of forecast period in 2027?
Structural Heart Devices Market – Research Objectives and Research Methodology

The making of the report involved extensive primary and secondary research carried out by seasoned analysts. They referred to proprietary databases and annual reports of companies for data collection. Secondary research involved reaching out to company websites, government websites, industrial publications, journals, trade associations, and government statistics. Face-to-face interviews carried out with industry leaders and opinion makers close the gaps between primary and secondary research.

Comprising a total of 14 sections, the entire compilation is presented in a chapter-wise layout for reading comprehensibility. The report contains an exhaustive collection of tables and graphs that are interspersed appropriately. Growth behaviour of key segments in the past as well as future projections are presented pictorially for ease of comparison.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Structural Heart Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Surge in awareness about structural heart diseases
4.3.1.2. Rise in prevalence of structural heart diseases
4.3.1.3. Increase in demand for minimally invasive procedures
4.3.1.4. Technological advancements in structural heart devices
4.3.1.5. Favorable reimbursement policies
4.3.1.6. Longer life expectancy along with increase in geriatric population
4.3.2. Restraints
4.3.2.1. Stringent government approval process
4.3.2.2. High cost of minimally invasive procedures
4.3.3. Opportunities
4.3.3.1. Lucrative opportunities in emerging markets
4.3.3.2. Increase in demand for heart valve repair procedures
4.4. Global Structural Heart Devices Market Analysis and Forecast, 2019–2027
5. Market Outlook
5.1. Product Mapping
5.2. Trials Mapping
5.3. Price Comparison Analysis
5.4. Technological Advancements
5.5. Key Industry Events
6. Global Structural Heart Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2019–2027
6.3.1. Biological/Tissue Valves
6.3.1.1. Transcatheter Heart Valves
6.3.1.2. Surgical Heart Valve
6.3.2. Mechanical Heart Valves
6.3.3. Annuloplasty Rings
6.3.4. Occluders
6.3.5. Accessories
6.4. Market Attractiveness, by Product
7. Global Structural Heart Devices Market Analysis and Forecast, by Procedure
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Procedure, 2019–2027
7.3.1. Replacement Procedure
7.3.2. Repair Procedure
7.4. Market Attractiveness, by Procedure
8. Global Structural Heart Devices Market Analysis and Forecasts, by Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Indication, 2019–2027
8.3.1. Valve Stenosis
8.3.2. Valve Regurgitation
8.3.3. Cardiomyopathy
8.3.4. Congenital Heart Defects
8.3.5. Others
8.4. Market Attractiveness, by Indication
9. Global Structural Heart Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Structural Heart Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2019–2027
10.2.1. Biological/Tissue Valves
10.2.1.1. Transcatheter Heart Valves
10.2.1.2. Surgical Heart Valve
10.2.2. Mechanical Heart Valves
10.2.3. Annuloplasty Rings
10.2.4. Occluders
10.2.5. Accessories
10.3. Market Value Forecast, by Procedure, 2019–2027
10.3.1. Replacement Procedure
10.3.2. Repair Procedure
10.4. Market Value Forecast, by Indication, 2019–2027
10.4.1. Valve Stenosis
10.4.2. Valve Regurgitation
10.4.3. Cardiomyopathy
10.4.4. Congenital Heart Defects
10.4.5. Others
10.5. Market Value Forecast, by Country, 2019–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Procedure
10.6.3. By Indication
10.6.4. By Country
11. Europe Structural Heart Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2019–2027
11.2.1. Biological/Tissue Valves
11.2.1.1. Transcatheter Heart Valves
11.2.1.2. Surgical Heart Valve
11.2.2. Mechanical Heart Valves
11.2.3. Annuloplasty Rings
11.2.4. Occluders
11.2.5. Accessories
11.3. Market Value Forecast, by Procedure, 2019–2027
11.3.1. Replacement Procedure
11.3.2. Repair Procedure
11.4. Market Value Forecast, by Indication, 2019–2027
11.4.1. Valve Stenosis
11.4.2. Valve Regurgitation
11.4.3. Cardiomyopathy
11.4.4. Congenital Heart Defects
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2019–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Procedure
11.6.3. By Indication
11.6.4. By Country/Sub-region
12. Asia Pacific Structural Heart Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2019–2027
12.2.1. Biological/ Tissue Valves
12.2.1.1. Transcatheter Heart Valves
12.2.1.2. Surgical Heart Valve
12.2.2. Mechanical Heart Valves
12.2.3. Annuloplasty Rings
12.2.4. Occluders
12.2.5. Accessories
12.3. Market Value Forecast, by Procedure, 2019–2027
12.3.1. Replacement Procedure
12.3.2. Repair Procedure
12.4. Market Value Forecast, by Indication, 2019–2027
12.4.1. Valve Stenosis
12.4.2. Valve Regurgitation
12.4.3. Cardiomyopathy
12.4.4. Congenital Heart Defects
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2019–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Procedure
12.6.3. By Indication
12.6.4. By Country/Sub-region
13. Latin America Structural Heart Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2019–2027
13.2.1. Biological/ Tissue Valves
13.2.1.1. Transcatheter Heart Valves
13.2.1.2. Surgical Heart Valve
13.2.2. Mechanical Heart Valves
13.2.3. Annuloplasty Rings
13.2.4. Occluders
13.2.5. Accessories
13.3. Market Value Forecast, by Procedure, 2019–2027
13.3.1. Replacement Procedure
13.3.2. Repair Procedure
13.4. Market Value Forecast, by Indication, 2019–2027
13.4.1. Valve Stenosis
13.4.2. Valve Regurgitation
13.4.3. Cardiomyopathy
13.4.4. Congenital Heart Defects
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2019–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Procedure
13.6.3. By Indication
13.6.4. By Country/Sub-region
14. Middle East & Africa Structural Heart Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2019–2027
14.2.1. Biological/ Tissue Valves
14.2.1.1. Transcatheter Heart Valves
14.2.1.2. Surgical Heart Valve
14.2.2. Mechanical Heart Valves
14.2.3. Annuloplasty Rings
14.2.4. Occluders
14.2.5. Accessories
14.3. Market Value Forecast, by Procedure, 2019–2027
14.3.1. Replacement Procedure
14.3.2. Repair Procedure
14.4. Market Value Forecast, by Indication, 2019–2027
14.4.1. Valve Stenosis
14.4.2. Valve Regurgitation
14.4.3. Cardiomyopathy
14.4.4. Congenital Heart Defects
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2019–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Procedure
14.6.3. By Indication
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. CryoLife, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Abbott
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Boston Scientific Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Edwards Lifesciences Corporation
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. LivaNova PLC
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Lepu Medical
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Micro Interventional Devices, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Lifetech Scientific
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview


List of Tables

Table 01: Structural Heart Device Product Mapping (1/6)
Table 02: Structural Heart Device Product Mapping (2/6)
Table 03: Structural Heart Device Product Mapping (3/6)
Table 04: Structural Heart Device Product Mapping (4/6)
Table 05: Structural Heart Device Product Mapping (5/6)
Table 06: Structural Heart Device Product Mapping (6/6)
Table 07: Ongoing Structural Heart Device Pipeline Analysis (1/7)
Table 08: Ongoing Structural Heart Device Pipeline Analysis (2/7)
Table 09: Ongoing Structural Heart Device Pipeline Analysis (3/7)
Table 10: Ongoing Structural Heart Device Pipeline Analysis (4/7)
Table 11: Ongoing Structural Heart Device Pipeline Analysis (5/7)
Table 12: Ongoing Structural Heart Device Pipeline Analysis (6/7)
Table 13: Ongoing Structural Heart Device Pipeline Analysis (7/7)
Table 14: Average Heart Valve Pricing (US$), 2017–2018
Table 15: Average Heart Valve Pricing (US$), 2017–2018
Table 16: Average Heart Valve Pricing (US$), 2017
Table 17: Global Structural Heart Devices Market, Product Launch and Regulatory Approvals, 2018–2019
Table 18: Global Structural Heart Devices Market, Product Launch and Regulatory Approvals, 2017–2018
Table 19: Global Structural Heart Devices Market, Product Launch and Regulatory Approvals, 2016–2017
Table 20: Global Structural Heart Devices Market, Acquisitions, 2016–2019
Table 21: Global Structural Heart Devices Market, Partnerships, Collaborations and Alliances, 2017–2019
Table 22: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 23: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Biological/Tissue Valves, 2017–2027
Table 24: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017–2027
Table 25: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017–2027
Table 26: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 27: North America Structural Heart Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 28: North America Structural Heart Devices Market Value (US$ Mn) Forecast, by Biological/Tissue Valves, 2017–2027
Table 29: North America Structural Heart Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2027
Table 30: North America Structural Heart Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 31: North America Structural Heart Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 32: Europe Structural Heart Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 33: Europe Structural Heart Devices Market Value (US$ Mn) Forecast, by Biological/Tissue Valves, 2017–2027
Table 34: Europe Structural Heart Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2027
Table 35: Europe Structural Heart Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 36: Europe Structural Heart Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 37: Asia Pacific Structural Heart Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 38: Asia Pacific Structural Heart Devices Market Value (US$ Mn) Forecast, by Biological/Tissue Valves, 2017–2027
Table 39: Asia Pacific Structural Heart Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2027
Table 40: Asia Pacific Structural Heart Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 41: Asia Pacific Structural Heart Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 42: Latin America Structural Heart Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 43: Latin America Structural Heart Devices Market Value (US$ Mn) Forecast, by Biological/Tissue Valves, 2017–2027
Table 44: Latin America Structural Heart Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2027
Table 45: Latin America Structural Heart Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 46: Latin America Structural Heart Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 47: Middle East & Africa Structural Heart Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 48: Middle East & Africa Structural Heart Devices Market Value (US$ Mn) Forecast, by Biological/Tissue Valves, 2017–2027
Table 49: Middle East & Africa Structural Heart Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2027
Table 50: Middle East & Africa Structural Heart Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 51: Middle East & Africa Structural Heart Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027